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1. Supplementary methods 
Supplementary methods 1 
MB primers 
MB exon 1 Forward  GCCATTGAGCGATCTTTG 
MB exon 1 Reverse  GATTCTCATGCTTCCTCCAG 
  
MB exon 2 Forward  GAAGTGAATGGCCCAAG 
MB exon 2 Reverse  TACCCATGGAGAGGATGC 
  
MB exon 3 Forward  CTCAATACACGGTCCTGGA 
MB exon 3 Reverse  ACAAAGCAGACACTCAGAAGC  
 
Supplementary methods 2 
Primers used for the haplotype analysis using microsatellite markers  
  
 
D22S685_fwd TTCTTAGTGGGGAAGGGATC 
D22S685_rev  TGAGTTTGATGTTTTTGATAGACA 
  
D22S691_fwd TCAAATTGGAGCCTCTTCTG 
D22S691_rev  GCTCATGTCTCCAAATGGAC 
 
D22S1152_fwd CTCAGGGTGCCTTGGAAT 
D22S1152_rev TGGGTCCTCTCAAAGCAAA 
   
D22S1265_fwd CAGGACAGTTCATGGAGCTT 
D22S1265_rev ATCCTTAAAGGCTCGGCTTA 
 D22S277_fwd TTCTTGTGTGGTAGTCTGGG 
D22S277_rev  TACCNACTCCCCAAACTATG 
 
D22S683_fwd AACAAAACAAAACAAAACAAACA 
D22S683_rev  GGTGGAAATGCCTCATGTAG 
  
D22S692_fwd AAGCTATGATCACGTCACTGC 
D22S692_rev  GGTGACTAGCCAATATCCTCC 
  
IL2RB_fwd  GCTAGATTTTCCCCGATGAT 
IL2RB_rev  ATGTAAAGTGCTCTCAAGAGTGC 
 
 
2. Supplementary notes 
Supplementary note 1 
MB aggregation test 
Following the identification of β-sheet structures in some sarcoplasmic bodies, we wanted to further 
investigate the capacity of the mutant MB to form amyloid fibrils in vitro by using infrared 
spectroscopy in combination with Thioflavin (ThT) fluorescence. Results of our analysis 
demonstrated that both the WT and mutant His98Tyr MB have some capacity to form β-sheet 
protein aggregates. This was demonstrated after the observation of an increased intensity at 1627 
cm
-1
 (typical of intermolecular β-sheet structures) (Supplementary Fig. 6) after 24h of MB 
incubation at 37°C and 200 rpm. However, the ThT measurements did not show any fluorescence 
increase during the monitored period (8 days) (data not shown), thus proving the absence of fibril 
formation under the used conditions.  
 
Supplementary note 2 
Molecular dynamics simulations 
We calculated the root mean square fluctuations (RMSF) per C atoms of both WT and p.His98Tyr 
mutant; the overlay of the corresponding RMSF profile is displayed in Supplementary Fig. 9. The 
RMSFs represent the standard deviation over time of the atomic positions with respect to the 
average structure within our sampling: therefore, they are a measure of the average atomic mobility. 
Almost superimposable RMSF profiles, as in Supplementary Fig. 9, provide a first evidence of very 
similar dynamic features for the two species. 
We next performed Essential Dynamics (ED) analysis, that allows for a thorough investigation of 
the conformational space spanned by a protein within a molecular dynamics simulation to 
characterize and visualize the principal motions associated to a species. As we are mostly interested 
in differences between the fluctuation patterns characterizing WT and p.His98Tyr mutant, we 
linked the equilibrated trajectories for the two species into a single MD ensemble (concatenated 
trajectory), performing ED analysis on it. We then projected the concatenated trajectory onto a 
plane defined by the first two eigenvectors of motions, which is usually referred to as the essential 
plane. This allows for a two-dimensional representation of the conformational landscape explored 
during the MD simulations, and for the calculation of the corresponding Free Energy Landscape 
(FEL). The result is displayed in Supplementary Fig. 10. Although displaying the FEL for both WT 
and p.His98Tyr, the contour plot shows a single minimum: this is a clear indication that the two 
proteins explore almost superimposable conformational spaces. Together, data displayed in 
Supplementary Figure 9 and 10, suggest that the protein dynamic is almost unaltered upon the 
substitution.  
3. Supplementary tables 
 
Supplementary Table 1: Summary of myopathological features in myoglobinopathy 
 
Family/ 
Individual 
Site of biopsy 
Years 
since 
disease 
onset 
Biopsy from a 
clinically 
affected muscle 
Sarcoplasmic 
bodies 
Fiber size 
variation 
Internal nuclei 
Fibro-fatty tissue  
proliferation 
Vacuoles 
Type I fiber 
predominance 
F1  
II:5 Deltoid 15 yes yes yes yes yes yes Yes 
II:7 Biceps 10 yes yes yes yes no yes Yes 
F2  
II:2 Biceps 30 yes yes yes yes no yes Yes 
F3  
III:5 
Ant tibialis 
Quadriceps 
8 yes yes Yes yes yes yes no 
III:9 Ant tibialis 2 yes yes Yes yes yes no no 
III:14 Ant tibialis -3 * no yes Yes yes no no no 
III:15 Ant tibialis -10 * no yes No no no no no 
IV:2 Ant tibialis -3 * no yes No no no no no 
IV:6 Ant tibialis 3 no yes No yes no no yes 
F4  
II: 6 Deltoid 10 yes yes Yes yes no yes yes 
F 5  
II: 4 Deltoid 10 yes yes Yes yes no yes yes 
F 6  
II: 4 Ant tibialis 3 no yes Yes yes no yes yes 
II:4 Quadriceps 6 yes yes Yes yes yes yes no 
II:4 Gastrocnemius 9 yes yes Yes yes no yes yes 
 
 *Minus sign before number indicates years before the onset of symptoms
 Supplementary Table 2: Haplotypes or alleles of the six families.  
 
      Family 5 three sibs  
Microsatellite Hg19 
position 
Family 1* Family 
2 
Family 
3 
Family 
4 
1 2 3 Family 
6 
D22685 34,595,593 302 302 310 306 306 306 306 306 306 306 314 314 
D22S691 34,875,643 222 242/246 223 255 246 242 246 242 246 242 247 223 
D22S1152 35,139,045 263 263 263 263 263 263 263 263 263 263 263 269 
D22S1265 35,389,908 176 176 176 206 200 191 200 191 200 191 176 188 
MB 36,002,811             
D22S277 36,271,500 162/166 162/166 156 150 160 160 160 160 160 160 166 158 
D22S683 36,513,691 246 216 226 222 216 246 216 246 216 246 224 230 
D22S692 37,125,545 156 160 160 152 160 160 160 160 160 160 160 156 
IL2RB 37,536,285 245 251/255 257 245 259 255 259 255 259 255 255 245 
 
*For families 1-4 the haplotype is the haplotype segregating with the disease in the Family. For Families 5 
and 6 the alleles in the affected individuals are shown. Double alleles eg 242/246 indicate uninformative 
markers  
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4. Supplementary figures 
 
Supplementary Figure 1: Cardiac MRI from patient F2, II: 2. Short axis images after 
gadolinium administration showing late transmural enhancement in basal and mid 
inferolateral segments (a, b) and in all of them at the apical level (c), indicative of 
fibrosis. 
 
 
Supplementary Figure 2: Autofluorescent aggregates on muscle biopsy. Unstained 
cryostat sections of skeletal muscle from patient F2, II: 2 viewed under confocal 
microscopy. The sarcoplasmic bodies exhibit autofluorescence emission in a wide range 
 8 
of visible laser excitation lines: 488nm (b), 543nm (c) and 633nm (d). Scale bars = 20 
µm. 
 
 
Supplementary Figure 3: Post-mortem cardiac pathological findings. Post-mortem 
analysis of myocardium from patient F1, VII showing large numbers of sarcoplasmic 
bodies in cardiac muscle. (a) HE; (b): electron microscopy. Scale bar in a = 20 µm, b = 
2 µm. 
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Supplementary Figure 4: Multipoint LOD score plot of the linkage region identified on 
chromosome 22 for Family 3.  
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Supplementary Figure 5: The p.His98Tyr variant involves a residue conserved to 
zebrafish.  
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Supplementary Figure 6: WT and His98Tyr MB variant in vitro aggregation test. (a) 
Second derivative spectra of MB-WT and MB-His98Tyr after different incubation 
times: MB-WT at 0 h in dark blue, MB-WT after 24 h in dark purple and MB-WT after 
96 h in dark cian. MB-His98Tyr at 0 h in wine, MB-His98Tyr after 24 h in red and MB-
His98Tyr after 96 h in orange. (b) β-sheet aggregation ratio (A1629 cm-1 /A1656 cm-1) 
of WT and mutant myoglobin at different incubation times. Boxplot denote the median 
(center line), interquartile range (box), whiskers that represents the most extreme data 
that is no more than 1.5xIQR from the edge of the box and oultiers that are the points  
outside this range.  
 
 
a 
b 
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Supplementary Figure 7: Time courses for heme dissociation from WT (blue) and 
p.His98Tyr (red). Reactions were carried out in 0.2 M phosphate buffer at pH 7.0 with 
0.45 M sucrose by mixing WT and p.His98Tyr with p.His65Tyr/Val69Phe 
apomyoglobin in 1 to10 concentration ratio. Time courses were monitored at 410 nm at 
37 °C for 360 min. 
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Supplementary Figure 8: Spectral features of WT and mutant myoglobin. UV-Vis 
absorption spectra highlighting changes in spectral features for WT (top) and His98Tyr 
mutant (bottom) upon transitions from deoxymyoglobin (black) to oxymyoglobin (red) 
and to metmyoglobin (blue). Spectra were collected in 20 mM phosphate buffer pH 7.4, 
at 37°C.  
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Supplementary Figure 9: Protein dynamics of WT and mutant myoglobin. Overlay of 
the root mean square fluctuations (RMSF) profiles for WT (black) and p.His98Tyr (red) 
human myoglobin. The RMSF profiles are almost superimposable, indicating that the 
mutation does not alter significantly the protein dynamics. 
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Supplementary Figure 10: Free energy landscapes for WT and mutant myoglobin. Free 
Energy Landscape (FEL) for the concatenated trajectory obtained by merging the 
sampled conformations for WT and p.His98Tyr proteins. All the conformations 
explored by a protein are associated with their corresponding (free) energy level, with 
the lowest energy levels being the most populated. The energy values associated with 
each possible distinct conformation are expressed with colors, here ranging from blue 
(low energy states, therefore high probability) to red (high energy, low probability). The 
dark blue spot on the plot represents a minimum, associated with low energy, stable 
conformations. The plot was created by projecting the simulated trajectory obtained by 
concatenating the individual trajectories obtained by molecular dynamics simulations 
for both the WT and the p.His98Tyr variant. There is a single minimum, suggesting that 
the two proteins are characterized by very similar dynamic properties. 
 
 
